Nurix Therapeutics, Inc. NRIX Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s free cash flow yield?
- Nurix Therapeutics, Inc. (NRIX) reported free cash flow yield of -16.6% in Q4 2025.
- How has Nurix Therapeutics, Inc.'s free cash flow yield changed year-over-year?
- Nurix Therapeutics, Inc.'s free cash flow yield increased by 3.7% year-over-year, from -17.2% to -16.6%.
- What is the long-term trend for Nurix Therapeutics, Inc.'s free cash flow yield?
- Over 3 years (2021 to 2025), Nurix Therapeutics, Inc.'s free cash flow yield has grown at a 28.1% compound annual growth rate (CAGR), from -7% to -14.7%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.